azathioprine has been researched along with Dermatomyositis, Adult Type in 125 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We observed a severe case of cerebral toxoplasmosis in a 22-year-old woman diagnosed with dermatomyositis in 2016 in Venezuela, and treated with rituximab and azathioprine." | 8.02 | Cerebral toxoplasmosis associated with treatment with rituximab, azathioprine and prednisone for dermatomyositis. ( Castaño-Amores, C; Nieto-Gómez, P, 2021) |
| " We report a case of severe anterograde amnesia caused by HHV-6 encephalitis in a young female patient on rituximab, azathioprine and prednisolone for dermatomyositis (DM)." | 7.85 | Human herpes virus-6 encephalitis causing severe anterograde amnesia associated with rituximab, azathioprine and prednisolone combination therapy for dermatomyositis. ( Baumer, T; Fry, C; Gunawardena, H; Luppe, S; Sieradzan, K, 2017) |
| " We report the successful use of oral cyclophosphamide, followed by azathioprine maintenance, in the treatment of a patient with dermatomyositis-related rapidly deteriorating ILD, resistant to steroid." | 7.72 | Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine. ( Mok, CC; Szeto, ML; To, CH, 2003) |
| "Low-dose oral methotrexate administered weekly is effective in treatment of the cutaneous manifestations of dermatomyositis and frequently enables a reduction or discontinuation of corticosteroid therapy." | 7.69 | Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. ( Callen, JP; Kasteler, JS, 1997) |
| "We report one case of dermatomyositis and one case of polymyositis and scleroderma in which the patients' condition improved after treatment with cyclosporine (cyclosporine A)." | 7.68 | Cyclosporine treatment for dermatomyositis/polymyositis. ( Mehregan, DR; Su, WP, 1993) |
| "Intensive immunosuppression (IIS) was compared with prednisolone alone over a 2-year period in the treatment of severe connective tissue diseases." | 7.66 | Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. ( Ansell, BM; de Vere Tyndall, A; Denman, AM; Gumpel, JM; Hollingworth, P; Mertin, J; Platts-Mills, T; Smith, DS, 1982) |
| "We describe an unusual hypersensitivity reaction to azathioprine occurring in a patient with dermatomyositis, in which the acute manifestations suggested an exacerbation of the patient's underlying disorder." | 7.65 | Azathioprine hypersensitivity mimicking an acute exacerbation of dermatomyositis. ( Goldenberg, DL; Stor, RA, 1975) |
| "Dermatomyositis is a known paraneoplastic syndrome that can complicate the course of a variety of different cancers, however, the association with HCC is extremely rare." | 5.35 | Remission of paraneoplastic dermatomyositis associated with hepatocellular carcinoma under prednisolone and azathiopin, and concommittant sorafenib. ( Apostolidis, L; Horstmann, S; Jäger, D; Kahlert, C; Lordick, F; Siegmund, A; Thom, R, 2009) |
| " In two patients the corticosteroid dosage could be tapered." | 5.27 | Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. ( Bickers, DR; Callen, JP; Hanno, R; Hawkins, C; Voorhees, JJ; Woo, TY, 1984) |
| " Cyclosporine or tacrolimus have shown efficacy in myositis including those patients with interstitial lung disease (ILD), whereas mycophenolate mofetil is effective in both polymyositis and refractory dermatomyosits (including recalcitrant rash) and ILD." | 4.88 | Therapeutic advances in myositis. ( Aggarwal, R; Oddis, CV, 2012) |
| "A 66-year-old female with dermatomyositis (DM) who had received immunosuppressive therapy with azathioprine developed acute myeloid leukaemia (AML)." | 4.80 | Azathioprine-associated acute myeloid leukaemia with trilineage dysplasia and complex karyotype: a case report and review of the literature. ( Abdalla, SH; Arnold, JA; Ranson, SA, 1999) |
| "We observed a severe case of cerebral toxoplasmosis in a 22-year-old woman diagnosed with dermatomyositis in 2016 in Venezuela, and treated with rituximab and azathioprine." | 4.02 | Cerebral toxoplasmosis associated with treatment with rituximab, azathioprine and prednisone for dermatomyositis. ( Castaño-Amores, C; Nieto-Gómez, P, 2021) |
| " We report a case of severe anterograde amnesia caused by HHV-6 encephalitis in a young female patient on rituximab, azathioprine and prednisolone for dermatomyositis (DM)." | 3.85 | Human herpes virus-6 encephalitis causing severe anterograde amnesia associated with rituximab, azathioprine and prednisolone combination therapy for dermatomyositis. ( Baumer, T; Fry, C; Gunawardena, H; Luppe, S; Sieradzan, K, 2017) |
| "In patients with juvenile dermatomyositis, treatment with intravenous immunoglobulin and cyclosporine A were more frequent as compared to adult patients." | 3.81 | [Clinical features of patients with juvenile and adult dermatomyositis]. ( Dankó, K; Farkas, F; Nagy-Vince, M; Szalmás, O, 2015) |
| "We identified all patients treated for PM/DM-ILD and assessed cyclophosphamide (CYC), azathioprine (AZA) and mycophenolate (MMF) when used as first-line steroid sparing therapy for effects on pulmonary function variables, dyspnea and tolerance at six and twelve months." | 3.79 | A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis. ( Arrossi, V; Chapman, JT; Culver, DA; Mira-Avendano, IC; Parambil, JG; Xu, M; Yadav, R, 2013) |
| " In univariate analysis, older age at PM/DM onset, anemia, thrombocytopenia, leukopenia, diabetes mellitus, ILD, cancer, and non-use of azathioprine were associated with higher mortality (p = 0." | 3.77 | Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases. ( Chang, HC; Chen, IJ; Ho, HH; Kuo, CF; Luo, SF; See, LC; Shen, YM; Wu, YJ; Yu, KH, 2011) |
| " Three patients with long-standing polymyositis (PM) or dermatomyositis (DM) poorly responsive to prednisone combined with several immunosuppressants were given intravenous rituximab 1,000 mg on Days 0 and 14." | 3.73 | Rituximab as therapy for refractory polymyositis and dermatomyositis. ( Hausner-Sypek, DL; Noss, EH; Weinblatt, ME, 2006) |
| " We report the successful use of oral cyclophosphamide, followed by azathioprine maintenance, in the treatment of a patient with dermatomyositis-related rapidly deteriorating ILD, resistant to steroid." | 3.72 | Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine. ( Mok, CC; Szeto, ML; To, CH, 2003) |
| "Low-dose oral methotrexate administered weekly is effective in treatment of the cutaneous manifestations of dermatomyositis and frequently enables a reduction or discontinuation of corticosteroid therapy." | 3.69 | Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. ( Callen, JP; Kasteler, JS, 1997) |
| "A 47-year-old man with dermatomyositis and interstitial pneumonia had been treated with prednisolone since May, 1992, and with azathioprine since April, 1993." | 3.69 | [Primary pulmonary non-Hodgkin's lymphoma in a patient with dermatomyositis]. ( Arima, N; Kawamata, N; Kohyama, T; Mori, H; Tanaka, H; Terashi, K; Yamada, H; Yamaguchi, A, 1997) |
| "We report one case of dermatomyositis and one case of polymyositis and scleroderma in which the patients' condition improved after treatment with cyclosporine (cyclosporine A)." | 3.68 | Cyclosporine treatment for dermatomyositis/polymyositis. ( Mehregan, DR; Su, WP, 1993) |
| "Because a seven year old boy with severe dermatomyositis failed to respond to a six week treatment course with prednisone (60 mg/m2) and azathioprine (2 mg/kg/d), five plasma separations were performed." | 3.67 | [Plasma separation in severe juvenile dermatomyositis]. ( Michalk, DV; Scharf, JW, 1985) |
| "The overall prognosis for polymyositis and dermatomyositis has improved with the judicious use of corticosteroids, while azathioprine and other cytotoxic agents are of value in improving functional ability and decreasing the total steroid requirement." | 3.67 | Management of polymyositis and dermatomyositis. ( Ansell, BM, 1984) |
| "Kaposi's sarcoma occurred in a 65-year-old Mexican woman who had been treated for dermatomyositis with prednisone for 2 1/2 years and with azathioprine for four months." | 3.66 | Kaposi's sarcoma in a patient with dermatomyositis receiving immunosuppressive therapy. ( Serushan, M; Weiss, VC, 1982) |
| "Intensive immunosuppression (IIS) was compared with prednisolone alone over a 2-year period in the treatment of severe connective tissue diseases." | 3.66 | Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. ( Ansell, BM; de Vere Tyndall, A; Denman, AM; Gumpel, JM; Hollingworth, P; Mertin, J; Platts-Mills, T; Smith, DS, 1982) |
| "We describe an unusual hypersensitivity reaction to azathioprine occurring in a patient with dermatomyositis, in which the acute manifestations suggested an exacerbation of the patient's underlying disorder." | 3.65 | Azathioprine hypersensitivity mimicking an acute exacerbation of dermatomyositis. ( Goldenberg, DL; Stor, RA, 1975) |
| "Dermatomyositis and polymyositis are rare chronic inflammatory disorders with significant associated morbidity and mortality despite treatment." | 2.52 | The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review. ( McHugh, NJ; Tansley, SL; Vermaak, E, 2015) |
| "Dermatomyositis is characterized by marked clinical heterogeneity." | 2.43 | [The clinical spectrum of dermatomyositis]. ( Genth, E; Hunzelmann, N; Kaufmann, J; Krieg, T, 2005) |
| "Dermatomyositis is an idiopathic inflammatory myopathy with characteristic skin manifestations." | 2.41 | Dermatomyositis. ( Koler, RA; Montemarano, A, 2001) |
| " Medications included chronic use of prednisone, methotrexate, abatacept, cyclophosphamide, mycophenolate mofetil, rituximab, tofacitinib, and sildenafil." | 1.72 | Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis. ( Heller, T; Kleiner, DE; Lanis, A; Rider, LG; Shenoi, S; Vittal, A; Volochayev, R, 2022) |
| "In patients with severe or refractory juvenile dermatomyositis (DM), second-line treatments may be required." | 1.48 | Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling. ( Campanilho-Marques, R; Deakin, CT; Moraitis, E; Pilkington, CA; Pullenayegum, E; Simou, S; Wedderburn, LR, 2018) |
| "Subgroup of idiopathic inflammatory myopathies, the antisynthetase syndrome is a rare chronic autoimmune disease, which is characterised by the presence of antibodies directed against aminoacyl-t-RNA-synthetases (family of intracytoplasmic enzymes with a vital role in the protein synthesis)." | 1.42 | Interstitial lung disease as first clinical manifestation within the antisynthetase syndrome--dermatomyositis. ( Mlădinescu, OF; Oancea, C; Trăilă, D; Tudorache, V, 2015) |
| "Dermatomyositis is a known paraneoplastic syndrome that can complicate the course of a variety of different cancers, however, the association with HCC is extremely rare." | 1.35 | Remission of paraneoplastic dermatomyositis associated with hepatocellular carcinoma under prednisolone and azathiopin, and concommittant sorafenib. ( Apostolidis, L; Horstmann, S; Jäger, D; Kahlert, C; Lordick, F; Siegmund, A; Thom, R, 2009) |
| "Hypersensitivity pneumonitis was suspected." | 1.33 | Recurrent episodes of dermatomyositis-associated pneumonitis masquerading as hypersensitivity pneumonitis. ( Marik, PE; Vahid, B, 2006) |
| "Lipodystrophy was seen in 10/33 (30." | 1.33 | Twelve years experience of juvenile dermatomyositis in North India. ( Bansal, A; Singh, S, 2006) |
| "A case of dermatomyositis presented as bronchiolitis obliterans organizing pneumonia has been rarely reported." | 1.31 | Dermatomyositis without elevation of creatine kinase presented as bronchiolitis obliterans organizing pneumonia. ( Cho, HD; Choi, SJ; Ji, JD; Kang, KH; Kim, HK; Lee, YH; Shim, JJ; Song, GG, 2000) |
| "A series of 33 patients with juvenile dermatomyositis was reviewed in terms of their prognosis in relation to their drug therapy." | 1.30 | Drug therapy in juvenile dermatomyositis: follow-up study. ( Ng, YT; Ouvrier, RA; Wu, T, 1998) |
| "Although most patients with inclusion body myositis have characteristic muscle biopsy findings, some cannot be distinguished histologically early from polymyositis." | 1.29 | Inclusion body myositis: clinical and pathological boundaries. ( Amato, AA; Barohn, RJ; Bryan, WW; Gronseth, GS; Jackson, CE; Katz, JS; Wolfe, GI, 1996) |
| "A series of 29 children with dermatomyositis has been reviewed and the outcome compared between cases treated by us initially with a low dosage short duration course of corticosteroids, and those referred late and having had various different therapeutic regimens and usually more active and higher dosage drug schedules." | 1.27 | Drug treatment of juvenile dermatomyositis. ( Dubowitz, V; Heckmatt, JZ; Miller, G, 1983) |
| " In two patients the corticosteroid dosage could be tapered." | 1.27 | Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. ( Bickers, DR; Callen, JP; Hanno, R; Hawkins, C; Voorhees, JJ; Woo, TY, 1984) |
| "Analysis of the response to corticosteroid therapy in a personal series of 8 consecutive cases of dermatomyositis in childhood shows that there are advantages in a moderate dosage, short-term treatment schedule, with gradual tapering of the dosage as soon as there is clinical improvement without waiting for full remission, and in trying to stop steroid therapy within six months rather than following the more prolonged regimen currently still in vogue." | 1.26 | Treatment of dermatomyositis in childhood. ( Dubowitz, V, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 63 (50.40) | 18.7374 |
| 1990's | 17 (13.60) | 18.2507 |
| 2000's | 23 (18.40) | 29.6817 |
| 2010's | 19 (15.20) | 24.3611 |
| 2020's | 3 (2.40) | 2.80 |
| Authors | Studies |
|---|---|
| Lanis, A | 1 |
| Volochayev, R | 1 |
| Kleiner, DE | 1 |
| Vittal, A | 1 |
| Heller, T | 1 |
| Rider, LG | 1 |
| Shenoi, S | 1 |
| Castaño-Amores, C | 1 |
| Nieto-Gómez, P | 1 |
| Akome, J | 1 |
| Kotobuki, Y | 1 |
| Maeda, T | 1 |
| Nojima, S | 1 |
| Shimada, N | 1 |
| Nakagawa, Y | 1 |
| Yamaoka, T | 1 |
| Kiyohara, E | 1 |
| Katayama, I | 1 |
| Wataya-Kaneda, M | 1 |
| Fujimoto, M | 1 |
| Deakin, CT | 1 |
| Campanilho-Marques, R | 1 |
| Simou, S | 1 |
| Moraitis, E | 1 |
| Wedderburn, LR | 1 |
| Pullenayegum, E | 1 |
| Pilkington, CA | 1 |
| Hartung, DM | 1 |
| Johnston, K | 1 |
| Cohen, DM | 1 |
| Nguyen, T | 1 |
| Deodhar, AA | 1 |
| Bourdette, DN | 1 |
| Keyßer, G | 1 |
| Zierz, S | 1 |
| Kornhuber, M | 1 |
| Palawisuth, S | 1 |
| Kantikosum, K | 1 |
| Patiyasikunt, M | 1 |
| Sriprasart, T | 1 |
| Asawanonda, P | 1 |
| Rerknimitr, P | 1 |
| Mira-Avendano, IC | 1 |
| Parambil, JG | 1 |
| Yadav, R | 1 |
| Arrossi, V | 1 |
| Xu, M | 1 |
| Chapman, JT | 1 |
| Culver, DA | 1 |
| Xuan, D | 1 |
| Yu, Y | 1 |
| Shao, L | 1 |
| Wang, J | 1 |
| Zhang, W | 1 |
| Zou, H | 1 |
| Adelowo, OO | 1 |
| Edomwonyi, U | 1 |
| Olaosebikan, H | 1 |
| Vermaak, E | 1 |
| Tansley, SL | 1 |
| McHugh, NJ | 1 |
| Trăilă, D | 1 |
| Mlădinescu, OF | 1 |
| Oancea, C | 1 |
| Tudorache, V | 1 |
| Szalmás, O | 1 |
| Nagy-Vince, M | 1 |
| Dankó, K | 2 |
| Farkas, F | 1 |
| Wu, PH | 1 |
| Lin, YT | 1 |
| Yang, YH | 1 |
| Lin, YC | 2 |
| Paik, JJ | 1 |
| Christopher-Stine, L | 1 |
| Baumer, T | 1 |
| Fry, C | 1 |
| Luppe, S | 1 |
| Gunawardena, H | 1 |
| Sieradzan, K | 1 |
| Kavala, M | 1 |
| Sudogan, S | 1 |
| Can, B | 1 |
| Zindanci, I | 1 |
| Kuru, I | 1 |
| Beyhan, S | 1 |
| Kocaturk, E | 1 |
| Apostolidis, L | 1 |
| Kahlert, C | 1 |
| Siegmund, A | 1 |
| Thom, R | 1 |
| Horstmann, S | 1 |
| Jäger, D | 1 |
| Lordick, F | 1 |
| Chakour, R | 1 |
| Leimgruber, A | 1 |
| Bart, PA | 2 |
| Spertini, F | 1 |
| Choy, EH | 2 |
| Hoogendijk, JE | 2 |
| Lecky, B | 2 |
| Winer, JB | 2 |
| Gordon, P | 1 |
| Yu, KH | 1 |
| Wu, YJ | 1 |
| Kuo, CF | 1 |
| See, LC | 1 |
| Shen, YM | 1 |
| Chang, HC | 1 |
| Luo, SF | 1 |
| Ho, HH | 1 |
| Chen, IJ | 1 |
| Vincze, M | 1 |
| Jung, KD | 1 |
| Kim, PS | 1 |
| Park, HY | 1 |
| Kim, CR | 1 |
| Byun, JY | 1 |
| Lee, DY | 1 |
| Lee, JH | 1 |
| Yang, JM | 1 |
| Lee, ES | 1 |
| Schiopu, E | 1 |
| Phillips, K | 1 |
| MacDonald, PM | 1 |
| Crofford, LJ | 1 |
| Somers, EC | 1 |
| Aggarwal, R | 1 |
| Oddis, CV | 1 |
| Queirós, G | 1 |
| Romeira, AM | 1 |
| Brito, MJ | 1 |
| Conde, M | 1 |
| Jayakumar, D | 1 |
| Chellapandian, D | 1 |
| Ramasekar, K | 1 |
| Raj, TE | 1 |
| Hall, VC | 1 |
| Keeling, JH | 1 |
| Davis, MD | 1 |
| Botsios, C | 1 |
| Ostuni, P | 1 |
| Boscolo-Rizzo, P | 1 |
| Da Mosto, MC | 1 |
| Punzi, L | 1 |
| Marchiori, C | 1 |
| Mok, CC | 1 |
| To, CH | 1 |
| Szeto, ML | 1 |
| GOLDSTEIN, G | 1 |
| Gainon, J | 1 |
| Waeber, G | 1 |
| Kokotis, P | 1 |
| Theodossiadis, P | 1 |
| Bouros, C | 1 |
| Sfikakis, PP | 1 |
| Singh, S | 1 |
| Bansal, A | 1 |
| Kaşifoğlu, T | 1 |
| Korkmaz, C | 1 |
| Ozkan, R | 1 |
| Kaufmann, J | 1 |
| Hunzelmann, N | 1 |
| Genth, E | 1 |
| Krieg, T | 1 |
| Noss, EH | 1 |
| Hausner-Sypek, DL | 1 |
| Weinblatt, ME | 1 |
| Ito, A | 1 |
| Umeda, M | 1 |
| Koike, T | 1 |
| Naruse, S | 1 |
| Fujita, N | 1 |
| Vahid, B | 1 |
| Marik, PE | 1 |
| Tweezer-Zaks, N | 1 |
| Ben-Horin, S | 1 |
| Schiby, G | 1 |
| Bank, I | 1 |
| Levi, Y | 1 |
| Livneh, A | 1 |
| Langevitz, P | 1 |
| Iorizzo, LJ | 1 |
| Jorizzo, JL | 1 |
| Hollingworth, P | 1 |
| de Vere Tyndall, A | 1 |
| Ansell, BM | 2 |
| Platts-Mills, T | 1 |
| Gumpel, JM | 1 |
| Mertin, J | 1 |
| Smith, DS | 2 |
| Denman, AM | 2 |
| Zabel, P | 1 |
| Leimenstoll, G | 1 |
| Gross, WL | 1 |
| Woo, TY | 1 |
| Callen, JP | 2 |
| Voorhees, JJ | 1 |
| Bickers, DR | 1 |
| Hanno, R | 1 |
| Hawkins, C | 1 |
| Rowen, AJ | 1 |
| Reichel, J | 1 |
| Fergusson, RJ | 1 |
| Davidson, NM | 1 |
| Nuki, G | 1 |
| Crompton, GK | 1 |
| Miller, G | 1 |
| Heckmatt, JZ | 1 |
| Dubowitz, V | 2 |
| Ahmed, AR | 1 |
| Moy, R | 1 |
| Weiss, VC | 1 |
| Serushan, M | 1 |
| Resnick, JS | 1 |
| Mammel, M | 1 |
| Mundale, MO | 1 |
| Kottke, FJ | 1 |
| King, LE | 1 |
| Park, JH | 1 |
| Adams, LB | 1 |
| Olsen, NJ | 1 |
| Jani, FM | 1 |
| Gray, JP | 1 |
| Lanham, J | 1 |
| Grau, JM | 1 |
| Herrero, C | 1 |
| Casademont, J | 1 |
| Fernández-Solà, J | 1 |
| Urbano-Márquez, A | 1 |
| Mehregan, DR | 1 |
| Su, WP | 1 |
| Amato, AA | 1 |
| Gronseth, GS | 1 |
| Jackson, CE | 1 |
| Wolfe, GI | 1 |
| Katz, JS | 1 |
| Bryan, WW | 1 |
| Barohn, RJ | 1 |
| Kasteler, JS | 1 |
| Villalba, L | 1 |
| Adams, EM | 1 |
| Schaller, M | 1 |
| Korting, HC | 1 |
| Meurer, M | 1 |
| Schirren, CG | 1 |
| Mori, H | 1 |
| Yamada, H | 1 |
| Terashi, K | 1 |
| Kohyama, T | 1 |
| Kawamata, N | 1 |
| Yamaguchi, A | 1 |
| Arima, N | 1 |
| Tanaka, H | 1 |
| Ng, YT | 1 |
| Ouvrier, RA | 1 |
| Wu, T | 1 |
| Arnold, JA | 1 |
| Ranson, SA | 1 |
| Abdalla, SH | 1 |
| Lee, YH | 1 |
| Choi, SJ | 1 |
| Ji, JD | 1 |
| Shim, JJ | 1 |
| Kang, KH | 1 |
| Cho, HD | 1 |
| Kim, HK | 1 |
| Song, GG | 1 |
| Komócsi, A | 1 |
| Kumánovics, G | 1 |
| Zibotics, H | 1 |
| Czirják, L | 1 |
| Mimura, T | 1 |
| Kanda, H | 1 |
| Kubo, K | 1 |
| Koler, RA | 1 |
| Montemarano, A | 1 |
| Pirofsky, B | 1 |
| Bardana, EJ | 1 |
| Schulze, P | 1 |
| Alexander, M | 1 |
| Kampf, D | 1 |
| Nemet, D | 1 |
| Stambuk, D | 1 |
| Brzović, Z | 1 |
| Plasaj, M | 1 |
| Jacobs, JC | 2 |
| Mazzei, D | 1 |
| Polli, EE | 1 |
| Quarto di Palo, F | 1 |
| Jerusalem, F | 1 |
| Wirth, W | 1 |
| Diekmann, L | 1 |
| Klokenbusch, S | 1 |
| Bradley, WG | 1 |
| Walton, JN | 1 |
| Pelton, BK | 1 |
| Kinsley, M | 1 |
| Knight, S | 1 |
| Partridge, C | 1 |
| Walker, P | 1 |
| Bannister, B | 1 |
| Gumpel, M | 1 |
| Loewi, E | 1 |
| Goldenberg, DL | 1 |
| Stor, RA | 1 |
| Hamilton, EB | 1 |
| Stoll, T | 1 |
| Michel, BA | 1 |
| Neidhart, M | 1 |
| Wassmer, P | 1 |
| Neidl, K | 1 |
| Fehr, K | 1 |
| Wagenhäuser, FJ | 1 |
| Ehrenstein, MR | 1 |
| Snaith, ML | 1 |
| Isenberg, DA | 1 |
| Pereira, RM | 1 |
| Lerner, S | 1 |
| Maeda, WT | 1 |
| Goldenstein-Schainberg, C | 1 |
| Cossermelli, W | 1 |
| Savage, MW | 1 |
| Clarke, CE | 1 |
| Yuill, GM | 1 |
| Ramírez, G | 1 |
| Asherson, RA | 1 |
| Khamashta, MA | 1 |
| Cervera, R | 1 |
| D'Cruz, D | 1 |
| Hughes, GR | 1 |
| Casato, M | 1 |
| Bonomo, L | 1 |
| Caccavo, D | 1 |
| Giorgi, A | 1 |
| Sabouraud, O | 1 |
| Clements, PJ | 1 |
| Davis, J | 1 |
| Lane, RJ | 1 |
| Fulthorpe, JJ | 1 |
| Hudgson, P | 1 |
| Lim, R | 1 |
| Parker, JL | 1 |
| Gruhn, WB | 1 |
| Diaz-Buxo, JA | 1 |
| Sattar, MA | 1 |
| Al-Sughyer, AA | 1 |
| Siboo, R | 1 |
| Kingston, WJ | 1 |
| Moxley, RT | 1 |
| Miller, LC | 1 |
| Michael, AF | 1 |
| Kim, Y | 1 |
| Nashel, DJ | 1 |
| Achurra Castillo, AF | 1 |
| Bulgín, O | 1 |
| López, RI | 1 |
| Benítez, R | 1 |
| Llerena, JM | 1 |
| Villarreal, V | 1 |
| Sandoval, E | 1 |
| Scharf, JW | 1 |
| Michalk, DV | 1 |
| Tilz, GP | 1 |
| Lurati, M | 1 |
| Mertens, HG | 1 |
| Schrago, R | 1 |
| Miescher, PA | 1 |
| Götzel, L | 1 |
| Delespesse, G | 1 |
| Kennes, B | 1 |
| Duchateau, J | 1 |
| Robitaille, P | 1 |
| Garbsch, H | 1 |
| Radl, H | 1 |
| Wysocka, K | 1 |
| Petrus, B | 1 |
| Skinner, MD | 1 |
| Schwartz, RS | 1 |
| Sneddon, I | 1 |
| Wishart, JM | 2 |
| Wishart, J | 1 |
| Chlud, K | 1 |
| Lechner, E | 1 |
| Banzhaf, M | 1 |
| Göpel, W | 1 |
| Lewkonia, RM | 1 |
| Buxton, PH | 1 |
| Kerl, H | 1 |
| Klein, G | 1 |
| Sandhofer, M | 1 |
| Grahmann, H | 1 |
| Möller, WD | 1 |
| Lever, WF | 1 |
| Nebe, H | 1 |
| Stögmann, W | 1 |
| Heidelmann, G | 1 |
| Fleischer, J | 1 |
| Schwenke, R | 1 |
| Cruchaud, A | 1 |
| Schuppli, R | 1 |
| Golacka, K | 1 |
| Tarka, Z | 1 |
| McFarlin, DE | 1 |
| Griggs, RC | 1 |
| Klemm, D | 1 |
| Blümchen, G | 1 |
| Chernosky, ME | 1 |
25 reviews available for azathioprine and Dermatomyositis, Adult Type
| Article | Year |
|---|---|
Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Arthritis, Rheumatoid; Azathioprine; Cohort Studies; Derm | 2014 |
Inflammatory myopathies in Nigerians: case series and literature review.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Dermatomyositis; Electromyography; Female; Humans; Imm | 2013 |
The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
Topics: Adrenal Cortex Hormones; Azathioprine; Biological Products; Cyclosporine; Dermatomyositis; Evidence- | 2015 |
An extremely severe case of cutaneous calcinosis complicating adult dermatomyositis.
Topics: Adult; Antirheumatic Agents; Azathioprine; Calcinosis; Dermatomyositis; Drug Therapy, Combination; F | 2009 |
WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Topics: Azathioprine; Blood Component Removal; Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agen | 2009 |
[New therapeutic approaches for polymyositis and dermatomyositis].
Topics: Adrenal Cortex Hormones; Algorithms; Antineoplastic Agents; Azathioprine; Biological Therapy; Cell M | 2011 |
Therapeutic advances in myositis.
Topics: Azathioprine; Cyclosporine; Dermatomyositis; Drug Resistance; Drug Therapy, Combination; Glucocortic | 2012 |
Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Topics: Azathioprine; Blood Component Removal; Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agen | 2005 |
[The clinical spectrum of dermatomyositis].
Topics: Adult; Age Factors; Azathioprine; Biopsy; Child; Clinical Trials as Topic; Cyclophosphamide; Cyclosp | 2005 |
The treatment and prognosis of dermatomyositis: an updated review.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Azathioprine; Cyclosporine; Dermatomyositis; Drug Admini | 2008 |
Azathioprine.
Topics: Arthritis, Rheumatoid; Azathioprine; Behcet Syndrome; Bone Marrow; Colitis, Ulcerative; Crohn Diseas | 1981 |
Update on therapy for refractory dermatomyositis and polymyositis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combinati | 1996 |
Azathioprine-associated acute myeloid leukaemia with trilineage dysplasia and complex karyotype: a case report and review of the literature.
Topics: Acute Disease; Aged; Azathioprine; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Leukem | 1999 |
[Treatment of steroid-resistant polymyositis and dermatomyositis].
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatomyositis; Dr | 2001 |
Dermatomyositis.
Topics: Adult; Azathioprine; Child; Dermatologic Agents; Dermatomyositis; Diagnosis, Differential; Female; H | 2001 |
Immunosuppressive therapy in rheumatic disease.
Topics: Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Dermatomyositis; Gr | 1977 |
[Indications and limits of long-term therapy with immunosuppressive (and cytostatic) agents in various chronic skin diseases].
Topics: Arthritis, Reactive; Azathioprine; Chronic Disease; Cyclophosphamide; Dermatomyositis; Humans; Immun | 1977 |
[Treatment of myopathies and spinal muscular atrophies (author's transl)].
Topics: Amyotrophic Lateral Sclerosis; Azathioprine; Collagen Diseases; Dermatomyositis; Glycogen Storage Di | 1978 |
[Polymyositis: disease course and therapy with intravenously administered immunoglobulins].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Clinical Enzyme Tests; Cyclophosphamide; Dermatomyosit | 1992 |
Cytotoxic drugs: their clinical application to the rheumatic diseases.
Topics: Arthritis; Arthritis, Rheumatoid; Azathioprine; Behcet Syndrome; Bone Marrow; Cell Division; Chemica | 1986 |
Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis.
Topics: Adult; Azathioprine; Cyclosporins; Dermatomyositis; Drug Resistance; Female; Humans; Myositis; Predn | 1987 |
Treatment of muscular dystrophies and inflammatory myopathies.
Topics: Azathioprine; Clinical Trials as Topic; Dermatomyositis; Humans; Muscular Dystrophies; Myositis; Myo | 1986 |
Mechanisms of action and clinical applications of cytotoxic drugs in rheumatic disorders.
Topics: Arthritis, Reactive; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Collagen Diseases; Cyclophos | 1985 |
[Auto-immune diseases and immunodepressive therapy. II. Current clinical indications].
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Arteritis; Autoimmune | 1974 |
Immunosuppressive therapy. 1.
Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid | 1972 |
5 trials available for azathioprine and Dermatomyositis, Adult Type
| Article | Year |
|---|---|
Cyclosporine A as first choice therapy for dermatomyositis.
Topics: Adult; Aged; Azathioprine; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; | 1994 |
Immunosuppressive therapy in rheumatic disease.
Topics: Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Dermatomyositis; Gr | 1977 |
Treatment of muscular dystrophies and inflammatory myopathies.
Topics: Azathioprine; Clinical Trials as Topic; Dermatomyositis; Humans; Muscular Dystrophies; Myositis; Myo | 1986 |
[Induction of tolerance of heterologous protein in therapy with antilymphocytic globulin in man].
Topics: Adolescent; Adult; Aged; Animals; Antilymphocyte Serum; Azathioprine; Corneal Transplantation; Derma | 1972 |
Immunosuppressive therapy. 1.
Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid | 1972 |
98 other studies available for azathioprine and Dermatomyositis, Adult Type
| Article | Year |
|---|---|
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis.
Topics: Abatacept; Adolescent; Arthritis; Autoantibodies; Azathioprine; Calcinosis; Child; Cyclophosphamide; | 2022 |
Cerebral toxoplasmosis associated with treatment with rituximab, azathioprine and prednisone for dermatomyositis.
Topics: Adult; Azathioprine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Prednisone; Rituxim | 2021 |
Case of hepatosplenic T-cell lymphoma in a patient with dermatomyositis treated with prednisolone and azathioprine.
Topics: Azathioprine; Dermatomyositis; Humans; Lymphoma, T-Cell; Prednisolone | 2021 |
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
Topics: Antirheumatic Agents; Azathioprine; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Derma | 2018 |
Elephant in the room.
Topics: Adrenocorticotropic Hormone; Azathioprine; Dermatomyositis; Humans; Polymyositis | 2019 |
Treatment of adult idiopathic inflammatory myopathies with conventional immunosuppressive drugs : Results of a retrospective study.
Topics: Adult; Azathioprine; Connective Tissue Diseases; Dermatomyositis; Drug Therapy, Combination; Female; | 2019 |
A Bad Sign: Dermatomyositis with Interstitial Lung Disease.
Topics: Anti-Inflammatory Agents; Azathioprine; Dermatomyositis; Dexamethasone; Fatal Outcome; Humans; Immun | 2019 |
A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
Topics: Adult; Azathioprine; Cyclophosphamide; Dermatomyositis; Drug Administration Schedule; Drug Resistanc | 2013 |
Interstitial lung disease as first clinical manifestation within the antisynthetase syndrome--dermatomyositis.
Topics: Adult; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Biomarkers; Dermatomyositis; Disease P | 2015 |
[Clinical features of patients with juvenile and adult dermatomyositis].
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatomyositis; Female; Fol | 2015 |
The increased risk of active tuberculosis disease in patients with dermatomyositis - a nationwide retrospective cohort study.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cohort Studies; Databases, Factual; | 2015 |
A case of refractory dermatomyositis responsive to tofacitinib.
Topics: Azathioprine; Dermatomyositis; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agent | 2017 |
Human herpes virus-6 encephalitis causing severe anterograde amnesia associated with rituximab, azathioprine and prednisolone combination therapy for dermatomyositis.
Topics: Acyclovir; Adult; Amnesia, Anterograde; Antiviral Agents; Azathioprine; B-Lymphocytes; Dermatomyosit | 2017 |
Remission of paraneoplastic dermatomyositis associated with hepatocellular carcinoma under prednisolone and azathiopin, and concommittant sorafenib.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Benzenesulfonates; Carcinoma, Hepatoce | 2009 |
[Therapeutic strategies in idiopatic inflammatory myopathies].
Topics: Adolescent; Age Factors; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Biopsy; Dermatomyos | 2009 |
Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Dermatomyositis; Diabetes Complications; Female; Fo | 2011 |
Dermatomyositis associated with generalized subcutaneous edema and Evans syndrome.
Topics: Anemia, Hemolytic, Autoimmune; Azathioprine; Dermatomyositis; Edema; Female; Glucocorticoids; Humans | 2012 |
Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.
Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Azathioprine; Coh | 2012 |
Cyclosporine-induced haemolytic anaemia in a child with juvenile dermatomyositis.
Topics: Anemia, Hemolytic; Azathioprine; Child; Cyclosporine; Dermatomyositis; Diagnosis, Differential; Drug | 2012 |
Dermatomyositis.
Topics: Azathioprine; Biopsy, Needle; Dermatomyositis; Drug Therapy, Combination; Electromyography; Follow-U | 2002 |
Periorbital edema as the presenting sign of dermatomyositis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Dermatomyositis; Diagnosis, Differe | 2003 |
Dermatomyositis and malignancy of the pharynx in Caucasian patients: report of two observations.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Carcinoma, Squamous Cell; Combin | 2003 |
Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine.
Topics: Administration, Oral; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Dermatomyositis; Disease | 2003 |
A CASE OF DERMATOMYOSITIS TREATED WITH 6-MERCAPTOPURINE AND AZATHIOPRINE.
Topics: Antimetabolites; Azathioprine; Dermatomyositis; Drug Therapy; Humans; Mercaptopurine | 1965 |
[Can we predict the risk of malignancy associated with dermatomyositis?].
Topics: Adenocarcinoma; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprin | 2003 |
Bilateral ocular myositis as a late complication of dermatomyositis.
Topics: Adult; Azathioprine; Dermatomyositis; Drug Therapy, Combination; Electromyography; Humans; Immunoglo | 2005 |
Twelve years experience of juvenile dermatomyositis in North India.
Topics: Adolescent; Age of Onset; Azathioprine; Calcinosis; Child; Child, Preschool; Deglutition Disorders; | 2006 |
Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis.
Topics: Adult; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; De | 2006 |
Rituximab as therapy for refractory polymyositis and dermatomyositis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; Azathioprine; B-Lymp | 2006 |
[A case of dermatomyositis associated with chronic idiopathic myelofibrosis].
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Chronic Disease; Dermatomyositis; Drug Therapy, Combin | 2006 |
Recurrent episodes of dermatomyositis-associated pneumonitis masquerading as hypersensitivity pneumonitis.
Topics: Adult; Alveolitis, Extrinsic Allergic; Azathioprine; Biopsy; Dermatomyositis; Diagnosis, Differentia | 2006 |
Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Dermatomyositis; Fatal Outcome; Fem | 2006 |
Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Connective Tissue Diseases; Dermatomyos | 1982 |
[Treatment of an acute dermatomyositis with cyclosporin A].
Topics: Acute Disease; Adolescent; Azathioprine; Blood Platelets; Creatine Kinase; Cyclosporins; Dermatomyos | 1984 |
Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
Topics: Adenocarcinoma; Adolescent; Adult; Azathioprine; Dermatomyositis; Drug Therapy, Combination; Female; | 1984 |
Management of polymyositis and dermatomyositis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Calcinosis; Child; Child, Preschool; | 1984 |
Dermatomyositis with lung involvement, successfully treated with azathioprine.
Topics: Adult; Azathioprine; Dermatomyositis; Humans; Lung Diseases; Male; Myositis | 1983 |
Dermatomyositis and rapidly progressive fibrosing alveolitis.
Topics: Aged; Azathioprine; Dermatomyositis; Female; Humans; Male; Middle Aged; Prednisolone; Pulmonary Fibr | 1983 |
Drug treatment of juvenile dermatomyositis.
Topics: Acute Disease; Azathioprine; Child; Dermatomyositis; Drug Administration Schedule; Drug Therapy, Com | 1983 |
Kaposi's sarcoma in a patient with dermatomyositis receiving immunosuppressive therapy.
Topics: Azathioprine; Cell Count; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Methotrexate; M | 1982 |
Muscular strength as an index of response to therapy in childhood dermatomyositis.
Topics: Adolescent; Azathioprine; Biomechanical Phenomena; Child; Child, Preschool; Creatine Kinase; Dermato | 1981 |
Phosphorus 31 magnetic resonance spectroscopy for quantitative evaluation of therapeutic regimens in dermatomyositis.
Topics: Adenosine Triphosphate; Adult; Azathioprine; Dermatomyositis; Evaluation Studies as Topic; Female; F | 1995 |
Influenza vaccine and dermatomyositis.
Topics: Aged; Azathioprine; Biopsy; Dermatomyositis; Female; Humans; Influenza Vaccines; Muscles; Prednisolo | 1994 |
Cyclosporine treatment for dermatomyositis/polymyositis.
Topics: Azathioprine; Cyclosporine; Dermatomyositis; Female; Humans; Hydroxychloroquine; Middle Aged; Polymy | 1993 |
Inclusion body myositis: clinical and pathological boundaries.
Topics: Aged; Azathioprine; Biopsy; Creatine Kinase; Dermatomyositis; Diagnosis, Differential; Female; Human | 1996 |
Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Antimalarial | 1997 |
[Generalized Mycobacterium avium-intracellulare infection due to immunosuppressive therapy of paraneoplastic dermatomyositis].
Topics: Adenocarcinoma; Azathioprine; Biopsy; Breast Neoplasms; Dermatomyositis; Female; Fluocortolone; Huma | 1997 |
[Primary pulmonary non-Hodgkin's lymphoma in a patient with dermatomyositis].
Topics: Azathioprine; Dermatomyositis; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Lung N | 1997 |
Drug therapy in juvenile dermatomyositis: follow-up study.
Topics: Administration, Oral; Adolescent; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Der | 1998 |
Dermatomyositis without elevation of creatine kinase presented as bronchiolitis obliterans organizing pneumonia.
Topics: Azathioprine; Biopsy, Needle; Creatine Kinase; Cryptogenic Organizing Pneumonia; Dermatomyositis; Di | 2000 |
Alveolitis may persist during treatment that sufficiently controls muscle inflammation in myositis.
Topics: Adult; Aged; Azathioprine; Bronchoalveolar Lavage Fluid; Dermatomyositis; Drug Therapy, Combination; | 2001 |
[Hyperergic collagenoses. Clinical aspects, differential diagnosis and therapy (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Azathioprine; Child; Collagen Diseases; Cyclophosphamide; Derm | 1977 |
[Corticosteroid therapy of polymyositis].
Topics: Adult; Azathioprine; Dermatomyositis; Drug Administration Schedule; Drug Therapy, Combination; Femal | 1979 |
Treatment of dermatomyositis.
Topics: Azathioprine; Child, Preschool; Dermatomyositis; Female; Humans; Male; Methotrexate; Prednisone | 1977 |
Methotrexate and azathioprine treatment of childhood dermatomyositis.
Topics: Azathioprine; Child; Child, Preschool; Dermatomyositis; Dose-Response Relationship, Drug; Drug Thera | 1977 |
Malignancy after immunosuppressive therapy.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Dermatomyositis; Female; Humans; Immunosuppression Therap | 1977 |
[Problems of disseminated lupus erythematosus in infants and children].
Topics: Arthritis, Rheumatoid; Azathioprine; Child; Child, Preschool; Chloroquine; Dermatomyositis; Female; | 1978 |
Letter: Treatment of dermatomyositis.
Topics: Azathioprine; Dermatomyositis; Humans; Prednisone | 1976 |
Treatment of dermatomyositis in childhood.
Topics: Azathioprine; Blood Sedimentation; Calcinosis; Child; Child, Preschool; Creatine Kinase; Dermatomyco | 1976 |
The treatment of connective tissue diseases with antilymphocyte globulin.
Topics: Aged; Antilymphocyte Serum; Azathioprine; Collagen Diseases; Dermatomyositis; Drug Therapy, Combinat | 1976 |
Azathioprine hypersensitivity mimicking an acute exacerbation of dermatomyositis.
Topics: Acute Disease; Azathioprine; Dermatomyositis; Diagnosis, Differential; Drug Hypersensitivity; Female | 1975 |
Juvenile dermatomyositis.
Topics: Adolescent; Azathioprine; Child; Dermatomyositis; Female; Humans; Male; Prednisolone | 1976 |
Idiopathic myositis: a rheumatological view.
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Creatine Kinase; Der | 1992 |
Pericardial tamponade in juvenile dermatomyositis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cardiac Tamponade; Child; Chloroquine; Dermat | 1992 |
Silent nocardia cerebral abscesses in treated dermatomyositis.
Topics: Azathioprine; Brain Abscess; Dermatomyositis; Female; Humans; Middle Aged; Nocardia asteroides; Noca | 1990 |
Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment.
Topics: Adult; Azathioprine; Cyclophosphamide; Dermatomyositis; Female; Follow-Up Studies; Humans; Male; Met | 1990 |
Clinical effects of cyclosporin in dermatomyositis.
Topics: Azathioprine; Cyclosporins; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Middle Aged | 1990 |
[Immunodepressive agents in neurology].
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Azathioprine; Cyclophosphamide; Dermatomyositis; Huma | 1986 |
Inclusion body myositis: a case with associated collagen vascular disease responding to treatment.
Topics: Azathioprine; Cell Nucleus; Dermatomyositis; Drug Therapy, Combination; Humans; Inclusion Bodies; Ma | 1985 |
Apparent haematuria: an early sign in polymyositis.
Topics: Adult; Azathioprine; Cyclophosphamide; Dermatomyositis; Drug Therapy, Combination; Hematuria; Humans | 1988 |
Coexistence of rheumatoid arthritis, ankylosing spondylitis and dermatomyositis in a patient with diabetes mellitus and the associated linked HLA antigens.
Topics: Adult; Arthritis, Rheumatoid; Azathioprine; Dermatomyositis; Diabetes Mellitus, Type 1; Hand; HLA An | 1988 |
Childhood dermatomyositis. Clinical course and long-term follow-up.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Dermatomyositis; Drug Therapy, Combination; Femal | 1987 |
[Polymyositis and dermatomyositis in the metropolitan hospital complex of the Panama Department of Social Security. 1973. Clinical review and effects of treatment].
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Dermatomyositis; Female; Humans; Male; Methotrexate; M | 1985 |
[Plasma separation in severe juvenile dermatomyositis].
Topics: Azathioprine; Child; Combined Modality Therapy; Dermatomyositis; Drug Therapy, Combination; Humans; | 1985 |
[Immunosuppression of severe dermatomyositis with cytostatic drugs and thymectomy (author's transl)].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Chronic Disease; Dactinomycin; Dermatomyositis; Female | 1974 |
[The treatment of dermatomyositis].
Topics: Adolescent; Adrenocorticotropic Hormone; Alpha-Globulins; Antibodies, Antinuclear; Antimetabolites; | 1974 |
[Complications of immunosuppressive therapy using cytostatics in autoaggression diseases with special reference to cholestatic hepatosis].
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Chemical and Drug Induced Liver Injury; | 1973 |
[Detection of antibodies to soluble nucleoprotein and to deoxyribonucleic acid using a radioimmunologic method].
Topics: Antibodies; Antibodies, Antinuclear; Arthritis, Rheumatoid; Azathioprine; Collagen Diseases; Dermato | 1974 |
[Calcinosis universalis in dermatomyositis].
Topics: Azathioprine; Calcinosis; Cardiomegaly; Child; Dermatomyositis; Diagnosis, Differential; Electromyog | 1969 |
[Long-term treatment with imuran and methotrexate in rheumatoid conditions].
Topics: Arthritis, Rheumatoid; Azathioprine; Dermatomyositis; Humans; Methotrexate; Polyarteritis Nodosa; Ti | 1972 |
Immunosuppression and malignancy.
Topics: Adult; Azathioprine; Dermatomyositis; Female; Humans; Immunosuppression Therapy; Lymphoma, Large B-C | 1972 |
Reticulosarcoma of the vulva complicating dermatomyositis treated by immunosuppression.
Topics: Adult; Azathioprine; Dermatomyositis; Erythema; Female; Humans; Immunosuppressive Agents; Lymphoma, | 1973 |
Reticulosarcoma of vulva complicating azathioprine-treated dermatomyositis.
Topics: Adult; Azathioprine; Dermatomyositis; Female; Humans; Lymphoma, Non-Hodgkin; Vulvar Neoplasms | 1973 |
[Is dermatomyositis an indication for immunosuppressive treatment?].
Topics: Administration, Oral; Azathioprine; Dermatomyositis; Evaluation Studies as Topic; Female; Humans; Lo | 1972 |
[Dermatomyositis syndromes and their immunosuppressive therapy. (Report of 4 cases)].
Topics: Adult; Azathioprine; Dermatomyositis; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Pr | 1973 |
Myositis in father and daughter.
Topics: Adult; Alanine Transaminase; Azathioprine; Child; Creatine Kinase; Dermatomyositis; Female; Humans; | 1973 |
[Treatment of "collagen and autoimmune" diseases (author's transl)].
Topics: Adolescent; Adult; Aminobenzoates; Azathioprine; Chloroquine; Cyclophosphamide; Dermatomyositis; Dex | 1973 |
[Azathioprine therapy in mast severe dermatomyositis. Case report].
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Clinical Enzyme Tests; Creat | 1972 |
Dermatomyositis.
Topics: Adult; Azathioprine; Dermatomyositis; Humans; Male; Methotrexate; Prednisone; Remission, Spontaneous | 1972 |
[Experiences in administration of antimetabolites in treatment of dermatomyosis].
Topics: Adrenal Cortex Hormones; Adult; Aged; Antimetabolites; Azathioprine; Dermatomyositis; Female; Follow | 1972 |
[Experiences in the treatment of dermatomyositis with immunosuppressiva].
Topics: Azathioprine; Child; Child, Preschool; Chlorambucil; Dermatomyositis; Drug Resistance; Drug Toleranc | 1972 |
[Case report on the treatment with azathioprine of collagen diseases].
Topics: Adult; Arthritis; Autoimmune Diseases; Azathioprine; Chronic Disease; Collagen Diseases; Dermatomyos | 1971 |
[Immunosuppressive treatment of collagen diseases].
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Collagen Diseases; Cyclophosphamide; Dermatomyosi | 1969 |
[Treatment of dermatologic lesions using immunosuppressive agents and cytostatics].
Topics: Antineoplastic Agents; Azathioprine; Dermatomyositis; Fluorouracil; Humans; Immunosuppressive Agents | 1970 |
[Our experiences with Imuran treatment].
Topics: Aged; Anemia, Hemolytic; Antibody Formation; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprin | 1971 |
Treatment of inflammatory myopathies with azathioprine.
Topics: Adolescent; Azathioprine; Dermatomyositis; Female; Humans; Middle Aged; Myositis | 1968 |
[Treatment of dermatomyositis with azathioprine].
Topics: Adult; Azathioprine; Dermatomyositis; Female; Humans; Middle Aged | 1968 |
Dermatomyositis in a child.
Topics: Azathioprine; Child; Dermatomyositis; Female; Humans; Prednisone | 1969 |